Sort
21,281 grants matching “influenza”
Physics-based characterization of functionally relevant protein conformational dynamics
$221,612Mahmoud Moradi · University Of Arkansas At Fayetteville · R35 · FY2022 · GM
Innate Immune Control of Influenza Virus Infection
$221,497Kevin L Legge · University Of Iowa · R21 · FY2007 · AI
Novel H1N1 influenza protection via cross-reactive immunity
$221,484Anne Searls De Groot · Epivax, Inc. · R21 · FY2011 · AI
Vaccine immunogenicity and efficacy in the rhesus macaque/SHIV model
$221,478Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2019 · AI
In vivo characterization of RNA virus assembly lines with EM tomography
$221,469Jason Kenneth Lanman · Purdue University · R00 · FY2012 · GM
Define long non-coding RNA regulatory mechanisms of host response to influenza infection
$221,425Xinxia Peng · North Carolina State University Raleigh · R21 · FY2020 · AI
Development of COVID-19 and Cancer Tools with Artificial Intelligence
$221,395Bradford J Wood · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Low affinity CD8+ T cells in diabetes
$221,356Scripps Research Institute · P01 · FY2001 · DK
Low affinity CD8+ T cells in diabetes
$221,356Scripps Research Institute · P01 · FY2000 · DK
Low affinity CD8+ T cells in diabetes
$221,356Scripps Research Institute · P01 · FY2002 · DK
MATERNAL IMMUNIZATION TO PREVENT EARLY INFANT OTITIS MEDIA
$221,299University Of Minnesota Twin Cities · P50 · FY2000 · DC
Using the Default Effect to Promote Healthy Behavior
$221,260Gretchen B Chapman · Rutgers, The State Univ Of N.J. · R01 · FY2012 · AG
Targeted Gene Expression from NL63 Vaccine Vectors
$221,250Amy C Sims · Univ Of North Carolina Chapel Hill · R21 · FY2008 · AI
Human complement C4 isotypes in Lupus
$221,250Michael Craig Carroll · Boston Children'S Hospital · R21 · FY2017 · AI
Regulation of Th17 immune responses by serpinB1
$221,250Eileen Remold-O'Donnell · Boston Children'S Hospital · R21 · FY2017 · AI
Improving mRNA vaccines with extracellular vesicle-associated immunogens
$221,250Michael R. Farzan · Boston Children'S Hospital · R21 · FY2024 · AI
Endogenous ligand of the NK activating receptor NKp46
$221,250Judy Lieberman · Boston Children'S Hospital · R21 · FY2021 · AI
Influenza-specific memory responses mediated by human NK cells
$221,221Stephanie Jost · Beth Israel Deaconess Medical Center · R21 · FY2019 · AI
Novel vaccine to enhance breadth of influenza immunity by skin vaccination
$221,210Baozhong Wang · Georgia State University · R01 · FY2015 · AI
Safety and Immunogenicity of H3N2v Influenza Vaccine in Pediatric Populations - VTEU
$221,099Emmanuel B Walter · Duke University · N01 · FY2014 · AI
Emerging Infectious Diseases Training Program
$221,020Kathleen A. McDonough · Wadsworth Center · T32 · FY2011 · AI
Interaction between influenza virus and H. influenzae
$220,903Sally R. Sarawar · Torrey Pines Inst For Molecular Studies · R21 · FY2007 · AI
Discovery of broad-spectrum influenza antivirals with a high genetic barrier to drug resistance by targeting the viral polymerase
$220,848Jun Wang · University Of Arizona · R21 · FY2019 · AI
Memory CD4 T cell-mediated immunopathology in influenza infection
$220,725Donna L Farber · University Of Maryland Baltimore · R21 · FY2008 · AI
Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis Media
$220,675Jason W. Rosch · St. Jude Children'S Research Hospital · R21 · FY2025 · AI